Pfizer: The Tide Finally Turning

09:00am, Monday, 11'th Nov 2024
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant. With business and stock excess seemingly totally wrung out, and with expec
Donald Trump's electoral victory has shaken the market, mostly in a good way.
High yields aren't a warning indicator with these three stocks.
More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

Relative Strength Alert For Pfizer

11:34am, Friday, 08'th Nov 2024
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important
PFE's core portfolio and strategic acquisitions continue to deliver decent results, no matter the lumpy sales contribution from Comirnaty and Paxlovid. The company raised their FY2024 core portfolio s
I will highlight 10 high dividend yield companies which, I believe, are worth considering investing in for November 2024. Each company could increase your portfolio's ability to generate dividend inco
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d
One stock yields 6% today. Another has grown its dividend by 460% over the past decade.
Pfizer is trading above its 52-week low but is still a dirt cheap buy.

5 Industries to Watch in a Trump Administration

05:56pm, Wednesday, 06'th Nov 2024
Equities usually rise regardless of who assumes the White House. However, savvy, active investors understand the importance of analyzing specific industries under a new administration.
Here are five stocks with a discounted PEG ratio, BABA, PFE, VIRT, LDOS and EAT, suitable for GARP investors.
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, BTU, JAKK, GBX and PFE hold promise.
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Pfizer (PFE) or Novo Nordisk (NVO). But which of these two stocks presents investors with the better
These stocks near 52-week lows could be ready to rebound.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE